Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI)

Engel Law PLLC is investigating whether fair value to Spectrum shareholders will result from the proposed acquisition of each share of Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) by Assertio Holdings, Inc. for both of: (i) 0.1783 shares of Assertio common stock, and (ii) one CVR per Spectrum share worth up to an additional $0.20 per share.

The Firm’s investigation concerns:

(i) whether the Company’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction;
(ii) whether the merger consideration adequately compensates the Company’s shareholders; and
(iii) whether all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.

Join this Action

Spectrum Pharmaceuticals, Inc.

MM slash DD slash YYYY